Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation

scientific article published in April 2004

Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/CLC.4960270405
P932PMC publication ID6654552
P698PubMed publication ID15119693
P5875ResearchGate publication ID8585098

P50authorJohn KjekshusQ6243255
Anne G SembQ89845760
Torbjørn HolmQ114371002
Ragnhild WergelandQ114371011
Aina HognestadQ114371041
Pål AukrustQ47504859
Lars GullestadQ63256598
P2093author name stringArne K Andreassen
Oddvar Stokke
P2860cites workAtherosclerosis — An Inflammatory DiseaseQ26776972
Factors affecting long-term survival (>10 years) after cardiac transplantation in the cyclosporine eraQ73386862
Are statins anti-inflammatory? Issues in the design and conduct of the pravastatin inflammation C-reactive protein evaluationQ74207496
Effect of atorvastatin on plasma fibrinogenQ74282353
[Regulation of endothelial NO production by Rho GTPase]Q77896366
High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular diseaseQ28181305
Levels of soluble cell adhesion molecules in patients with dyslipidemiaQ28279951
Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cellsQ28379577
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)Q29547825
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsQ29620696
Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia.Q32007717
C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?Q33678964
C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarctionQ33883883
Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levelsQ33942737
Non-lipid-lowering effects of statins on atherosclerosisQ34027314
Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I.Q34429041
Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemiaQ34439645
Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study GroupQ39522420
HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathwayQ39946864
A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health StudyQ40818460
C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarctionQ40857092
Plasma concentration of C-reactive protein and risk of developing peripheral vascular diseaseQ40868032
Statins do more than just lower cholesterolQ41169571
Vascular effects of statins in strokeQ41642213
Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjectsQ43601429
PRINCE's prospects: statins, inflammation, and coronary riskQ43619566
Effects of simvastatin and atorvastatin on inflammation markers in plasmaQ43959187
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular eventsQ44216708
Fibrinogen and viscosity as risk factors for subsequent cardiovascular events in stroke survivorsQ48434703
Effects of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia.Q51581527
Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemiaQ58421218
Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humansQ71971748
C-reactive protein colocalizes with complement in human hearts during acute myocardial infarctionQ71971756
Effect of three fibrate derivatives and of two HMG-CoA reductase inhibitors on plasma fibrinogen level in patients with primary hypercholesterolemiaQ72595264
Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 monthQ73120271
P433issue4
P921main subjectendotheliumQ111140
P304page(s)199-203
P577publication date2004-04-01
P1433published inClinical CardiologyQ4502312
P1476titleEffects of conventional and aggressive statin treatment on markers of endothelial function and inflammation
P478volume27

Reverse relations

cites work (P2860)
Q43109248Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosis
Q83940492Antioxidant effects of simvastatin in primary and secondary prevention of coronary heart disease
Q33802886Association of statin use with cognitive decline in elderly African Americans
Q28174014Effect of statins and aspirin alone and in combination on clinical outcome in dyslipidaemic patients with coronary heart disease. A subgroup analysis of the GREACE study
Q46806024Enhanced acetylcholine-induced dilation in afferent arterioles in simvastatin-fed rats
Q42133595Impact of chronic anticholesterol therapy on development of microvascular rarefaction in the metabolic syndrome
Q33904404Moderate-dose atorvastatin improves arterial endothelial function in patients with angina pectoris and normal coronary angiogram: a pilot study
Q34769971Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trial
Q42949809Simvastatin-induced changes in circulating oxidized low-density lipoprotein in different types of dyslipidemia
Q36836591Statins and blood pressure: is there an effect or not?
Q38029526The antihypertensive actions of statins: modulation by salt intake
Q35880875The effect of aggressive versus conventional lipid-lowering therapy on markers of inflammatory and oxidative stress

Search more.